Critical Survey: OSR (NASDAQ:OSRH) & Blaize (NASDAQ:BZAI)

OSR (NASDAQ:OSRH) and Blaize (NASDAQ:BZAI) are both small-cap manufacturing companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership.

Earnings and Valuation

This table compares OSR and Blaize”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OSR	-$90,515.00	-208.02	-$2.41 million	($1.12)	-0.65
Blaize	$1.55 million	176.87	-$4.11 million	($0.71)	-3.48

OSR has higher earnings, but lower revenue than Blaize. Blaize is trading at a lower price-to-earnings ratio than OSR, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

55.3% of OSR shares are owned by institutional investors. Comparatively, 97.1% of Blaize shares are owned by institutional investors. 60.6% of OSR shares are owned by insiders. Comparatively, 17.4% of Blaize shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares OSR and Blaize’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OSR	N/A	-6.66%	-4.90%
Blaize	N/A	N/A	-31.40%

Risk & Volatility

OSR has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500. Comparatively, Blaize has a beta of 0.32, indicating that its share price is 68% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for OSR and Blaize, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OSR	1	0	0	0	1.00
Blaize	1	1	4	1	2.71

Blaize has a consensus price target of $7.60, suggesting a potential upside of 207.69%. Given Blaize’s stronger consensus rating and higher probable upside, analysts plainly believe Blaize is more favorable than OSR.

Summary

Blaize beats OSR on 9 of the 14 factors compared between the two stocks.

About OSR

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.

About Blaize

Blaize® has created a transformative new compute solution that unites silicon and software to optimize AI from the edge to the core. We’re partnering with customers to transform their products so they can deliver better experiences and better lives.